We haven’t tried one of these strategies in our lab yet, but if you’re willing to experiment, I would go for the RAD-51 option first.
I do not expect targeting 53BP1 (HSR-9) by inhibition or indirectly by using the RAD18 variant (if conserved) to have any effect on CRISPR outcomes, since TMEJ (and not NHEJ!!) generates the inherited CRISPR-induced indels in the C.elegans germline (https://www.ncbi.nlm.nih.gov/pubmed/26077599).
53BP1 prevents resection of break ends, thereby preventing HR and stimulating NHEJ. However, similar to HR, TMEJ also requires resected break ends. Therefore, inhibiting 53BP1 will probably not change the balance between HDR and TMEJ.